Downloads provided by UsageCounts
Abstract Background After ischemic stroke (IS), peripheral leukocytes infiltrate the damaged region and modulate the response to injury. Peripheral blood cells display distinctive gene expression signatures post-IS and these transcriptional programs reflect changes in immune responses to IS. Dissecting the temporal dynamics of gene expression after IS improves our understanding of immune and clotting responses at the molecular and cellular level that are involved in acute brain injury and may assist with time-targeted, cell-specific therapy. Methods The transcriptomic profiles from peripheral monocytes, neutrophils, and whole blood from 38 ischemic stroke patients and 18 controls were analyzed with RNA-seq as a function of time and etiology after stroke. Differential expression analyses were performed at 0–24 h, 24–48 h, and >48 h following stroke. Results Unique patterns of temporal gene expression and pathways were distinguished for monocytes, neutrophils, and whole blood with enrichment of interleukin signaling pathways for different time points and stroke etiologies. Compared to control subjects, gene expression was generally upregulated in neutrophils and generally downregulated in monocytes over all times for cardioembolic, large vessel, and small vessel strokes. Self-organizing maps identified gene clusters with similar trajectories of gene expression over time for different stroke causes and sample types. Weighted Gene Co-expression Network Analyses identified modules of co-expressed genes that significantly varied with time after stroke and included hub genes of immunoglobulin genes in whole blood. Conclusions Altogether, the identified genes and pathways are critical for understanding how the immune and clotting systems change over time after stroke. This study identifies potential time- and cell-specific biomarkers and treatment targets.
Aging, Stroke (mesh), Cerebrovascular, Neutrophils, Pathway analyses, 11 Medical and Health Sciences (for), Medical and Health Sciences, Monocytes, Clinical Research (rcdc), Aging (rcdc), transcriptomics, Monocytes (mesh), neutrophils, Brain Disorders (rcdc), Gene Regulatory Networks, 32 Biomedical and Clinical Sciences (for-2020), Neurosciences (rcdc), Humans (mesh), Time course, Ischemic stroke, WGCNA, R, Cerebrovascular (rcdc), pathway analyses, RNAseq, Stroke, Stroke (hrcs-hc), Blood, Gene Regulatory Networks (mesh), Medicine, monocytes, Hub genes, Biotechnology, Research Article, Neutrophils (mesh), General & Internal Medicine (science-metrix), 1.1 Normal biological development and functioning, Immunology, 610, Biotechnology (rcdc), Ischemic Stroke (mesh), Clinical Research, 42 Health sciences (for-2020), blood, General & Internal Medicine, Genetics, ischemic stroke, Humans, Transcriptomics, 3204 Immunology (for-2020), Ischemic Stroke, 1.1 Normal biological development and functioning (hrcs-rac), Biomedical and Clinical Sciences, Genetics (rcdc), Gene Expression Profiling, Human Genome, Neurosciences, Stroke (rcdc), Health sciences, hub genes, Transcriptome (mesh), Human Genome (rcdc), Gene Expression Profiling (mesh), Brain Disorders, 32 Biomedical and clinical sciences (for-2020), gene expression, Gene expression, RNA-seq, Transcriptome
Aging, Stroke (mesh), Cerebrovascular, Neutrophils, Pathway analyses, 11 Medical and Health Sciences (for), Medical and Health Sciences, Monocytes, Clinical Research (rcdc), Aging (rcdc), transcriptomics, Monocytes (mesh), neutrophils, Brain Disorders (rcdc), Gene Regulatory Networks, 32 Biomedical and Clinical Sciences (for-2020), Neurosciences (rcdc), Humans (mesh), Time course, Ischemic stroke, WGCNA, R, Cerebrovascular (rcdc), pathway analyses, RNAseq, Stroke, Stroke (hrcs-hc), Blood, Gene Regulatory Networks (mesh), Medicine, monocytes, Hub genes, Biotechnology, Research Article, Neutrophils (mesh), General & Internal Medicine (science-metrix), 1.1 Normal biological development and functioning, Immunology, 610, Biotechnology (rcdc), Ischemic Stroke (mesh), Clinical Research, 42 Health sciences (for-2020), blood, General & Internal Medicine, Genetics, ischemic stroke, Humans, Transcriptomics, 3204 Immunology (for-2020), Ischemic Stroke, 1.1 Normal biological development and functioning (hrcs-rac), Biomedical and Clinical Sciences, Genetics (rcdc), Gene Expression Profiling, Human Genome, Neurosciences, Stroke (rcdc), Health sciences, hub genes, Transcriptome (mesh), Human Genome (rcdc), Gene Expression Profiling (mesh), Brain Disorders, 32 Biomedical and clinical sciences (for-2020), gene expression, Gene expression, RNA-seq, Transcriptome
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 33 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
| views | 6 | |
| downloads | 21 |

Views provided by UsageCounts
Downloads provided by UsageCounts